Literature DB >> 30215057

Ischemic Conditioning and neonatal hypoxic ischemic encephalopathy: a literature review.

Dusit Adstamongkonkul1, David C Hess1.   

Abstract

Hypoxic Ischemic Encephalopathy (HIE) is the result of severe anoxic brain injury during the neonatal period and causes life-long morbidity and premature mortality. Currently, therapeutic hypothermia immediately after birth is the standard of care for clinically relevant HIE. However, therapeutic hypothermia alone does not provide complete neuroprotection and there is an urgent need for adjunctive therapies. Ischemic conditioning is an adaptive process of endogenous protection in which small doses of sub-lethal ischemia can provide a protection against a lethal ischemic event. Remote Ischemic Post-conditioning (RIPC), a form of ischemic conditioning, is highly translatable for HIE diagnosed immediately after birth as the conditioned ischemic stimulus is applied at the limb after the lethal ischemic episode. A number of studies in neonatal rats have demonstrated that RIPC is effective at reducing injury in focal cerebral ischemia models and improves neurological outcomes. In this review, we focus on the available data on HIE and its current treatment, models in HIE studies, ischemic conditioning/RIPC and its mechanism. We discuss in particular the effect of RIPC on neonatal brain with HIE. We postulate that combining RIPC with standard therapeutic hypothermia can be an attractive therapeutic approach for HIE.

Entities:  

Keywords:  hypothermia; hypoxic ischemic encephalopathy; remote ischemic post-conditioning

Year:  2017        PMID: 30215057      PMCID: PMC6131706     

Source DB:  PubMed          Journal:  Cond Med        ISSN: 2577-3240


  89 in total

1.  Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning.

Authors:  M R Schmidt; M Smerup; I E Konstantinov; M Shimizu; J Li; M Cheung; P A White; S B Kristiansen; K Sorensen; V Dzavik; A N Redington; R K Kharbanda
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-12-15       Impact factor: 4.733

Review 2.  Interventions for perinatal hypoxic-ischemic encephalopathy.

Authors:  R C Vannucci; J M Perlman
Journal:  Pediatrics       Date:  1997-12       Impact factor: 7.124

3.  Remote ischemic post-conditioning reduced brain damage in experimental ischemia/reperfusion injury.

Authors:  Changhong Ren; Mingqing Gao; David Dornbos; Yuchuan Ding; Xianwei Zeng; Yumin Luo; Xunming Ji
Journal:  Neurol Res       Date:  2011-06       Impact factor: 2.448

4.  Post-hypoxic hypothermia reduces cerebrocortical release of NO and excitotoxins.

Authors:  M Thoresen; S Satas; M Puka-Sundvall; A Whitelaw; A Hallström; E M Løberg; U Ungerstedt; P A Steen; H Hagberg
Journal:  Neuroreport       Date:  1997-10-20       Impact factor: 1.837

Review 5.  Treatment advances in neonatal neuroprotection and neurointensive care.

Authors:  Michael V Johnston; Ali Fatemi; Mary Ann Wilson; Frances Northington
Journal:  Lancet Neurol       Date:  2011-04       Impact factor: 44.182

6.  Effects of hypothermia and hyperthermia on attentional and spatial learning deficits following neonatal hypoxia-ischemic insult in rats.

Authors:  Kenichi Mishima; Tomoaki Ikeda; Tetsuya Yoshikawa; Naoya Aoo; Nobuaki Egashira; Yi X Xia; Tsuyomu Ikenoue; Katsunori Iwasaki; Michihiro Fujiwara
Journal:  Behav Brain Res       Date:  2004-05-05       Impact factor: 3.332

7.  Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome.

Authors:  E Bona; H Hagberg; E M Løberg; R Bågenholm; M Thoresen
Journal:  Pediatr Res       Date:  1998-06       Impact factor: 3.756

8.  Hydrogen peroxide increases GABAA receptor-mediated tonic current in hippocampal neurons.

Authors:  Antonello Penna; Dian-Shi Wang; Jieying Yu; Irene Lecker; Patricia M G E Brown; Derek Bowie; Beverley A Orser
Journal:  J Neurosci       Date:  2014-08-06       Impact factor: 6.167

9.  Protective effects of remote ischemic conditioning against ischemia/reperfusion-induced retinal injury in rats.

Authors:  Xuxiang Zhang; Yunneng Jizhang; Xiaoying Xu; Timothy D Kwiecien; Ning Li; Ying Zhang; Xunming Ji; Changhong Ren; Yuchuan Ding
Journal:  Vis Neurosci       Date:  2014-04-15       Impact factor: 3.241

10.  A rat model for hypoxic-ischemic brain damage in very premature infants.

Authors:  R A Sheldon; J Chuai; D M Ferriero
Journal:  Biol Neonate       Date:  1996
View more
  5 in total

1.  Near infrared light amplifies endothelial progenitor cell accumulation after stroke.

Authors:  Andrew Vahabzadeh-Hagh; Thomas J McCarthy; Luis De Taboada; Jackson Streeter; Alvaro Pascual-Leone; Eng H Lo; Kazuhide Hayakawa
Journal:  Cond Med       Date:  2019-08

2.  Effect of interplay between age and low-flow duration on neurologic outcomes of extracorporeal cardiopulmonary resuscitation.

Authors:  Hsi-Yu Yu; Chih-Hsien Wang; Nai-Hsin Chi; Shu-Chien Huang; Heng-Wen Chou; Nai-Kuan Chou; Yih-Sharng Chen
Journal:  Intensive Care Med       Date:  2018-12-13       Impact factor: 17.440

3.  Activation of GPR39 with TC-G 1008 attenuates neuroinflammation via SIRT1/PGC-1α/Nrf2 pathway post-neonatal hypoxic-ischemic injury in rats.

Authors:  Shucai Xie; Xili Jiang; Desislava Met Doycheva; Hui Shi; Peng Jin; Ling Gao; Rui Liu; Jie Xiao; Xiao Hu; Jiping Tang; Lina Zhang; John H Zhang
Journal:  J Neuroinflammation       Date:  2021-10-13       Impact factor: 8.322

4.  Remote ischemic postconditioning for neuroprotection after newborn hypoxia-ischemia: systematic review of preclinical studies.

Authors:  Ted C K Andelius; Tine B Henriksen; Birgitte S Kousholt; Kasper J Kyng
Journal:  Pediatr Res       Date:  2021-07-19       Impact factor: 3.953

5.  Efficacy of different treatment times of mild cerebral hypothermia on oxidative factors and neuroprotective effects in neonatal patients with moderate/severe hypoxic-ischemic encephalopathy.

Authors:  Tingting Yang; Shan Li
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.